Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 4Sanofi Genzyme, a division of sanofi-aventis Canada
01 22263319
02 22389767
01 4Vandetanib
01 4Tablet
01 22017-09-23
02 22020-11-01
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2020-11-01
Date Granted : 2010-03-23
Brand Name : CAPRELSA
Patent Number : 2389767
Filing Date : 2000-11-01
Strength per Unit : 100 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-11-01
Date Granted : 2010-03-23
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2017-09-23
Date Granted : 2004-03-23
Brand Name : CAPRELSA
Patent Number : 2263319
Filing Date : 1997-09-23
Strength per Unit : 100 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-09-23
Date Granted : 2004-03-23
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2017-09-23
Date Granted : 2004-03-23
Brand Name : CAPRELSA
Patent Number : 2263319
Filing Date : 1997-09-23
Strength per Unit : 300 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-09-23
Date Granted : 2004-03-23
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2020-11-01
Date Granted : 2010-03-23
Brand Name : CAPRELSA
Patent Number : 2389767
Filing Date : 2000-11-01
Strength per Unit : 300 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-11-01
Date Granted : 2010-03-23
LOOKING FOR A SUPPLIER?